Literature DB >> 12740363

Identification of a novel voltage-driven organic anion transporter present at apical membrane of renal proximal tubule.

Promsuk Jutabha1, Yoshikatsu Kanai, Makoto Hosoyamada, Arthit Chairoungdua, Do Kyung Kim, Yuji Iribe, Ellappan Babu, Ju Young Kim, Naohiko Anzai, Varanuj Chatsudthipong, Hitoshi Endou.   

Abstract

A novel transport protein with the properties of voltage-driven organic anion transport was isolated from pig kidney cortex by expression cloning in Xenopus laevis oocytes. A cDNA library was constructed from size-fractionated poly(A)+ RNA and screened for p-aminohippurate (PAH) transport in high potassium medium. A 1856-base pair cDNA encoding a 467-amino acid peptide designated as OATV1 (voltage-driven organic anion transporter 1) was isolated. The predicted amino acid sequence of OATV1 exhibited 60-65% identity to those of human, rat, rabbit, and mouse sodium-dependent phosphate cotransporter type 1 (NPT1), although OATV1 did not transport phosphate. The homology of this transporter to known members of the organic anion transporter family (OAT family) was about 25-30%. OATV1-mediated PAH transport was affected by the changes in membrane potential. The transport was Na+-independent and enhanced at high concentrations of extracellular potassium and low concentrations of extracellular chloride. Under the voltage clamp condition, extracellularly applied PAH induced outward currents in oocytes expressing OATV1. The current showed steep voltage dependence, consistent with the voltage-driven transport of PAH by OATV1. The PAH transport was inhibited by various organic anions but not by organic cations, indicating the multispecific nature of OATV1 for anionic compounds. This transport protein is localized at the apical membrane of renal proximal tubule, consistent with the proposed localization of a voltage-driven organic anion transporter. Therefore, it is proposed that OATV1 plays an important role to excrete drugs, xenobiotics, and their metabolites driven by membrane voltage through the apical membrane of the tubular epithelial cells into the urine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12740363     DOI: 10.1074/jbc.M303210200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Human SLC2A9a and SLC2A9b isoforms mediate electrogenic transport of urate with different characteristics in the presence of hexoses.

Authors:  Kate Witkowska; Kyla M Smith; Sylvia Y M Yao; Amy M L Ng; Debbie O'Neill; Edward Karpinski; James D Young; Christopher I Cheeseman
Journal:  Am J Physiol Renal Physiol       Date:  2012-05-30

Review 2.  Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles.

Authors:  Ahsan N Rizwan; Gerhard Burckhardt
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

Review 3.  Renal Drug Transporters and Drug Interactions.

Authors:  Anton Ivanyuk; Françoise Livio; Jérôme Biollaz; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

Review 4.  Recent advances in renal urate transport: characterization of candidate transporters indicated by genome-wide association studies.

Authors:  Naohiko Anzai; Promsuk Jutabha; Sirirat Amonpatumrat-Takahashi; Hiroyuki Sakurai
Journal:  Clin Exp Nephrol       Date:  2011-11-01       Impact factor: 2.801

5.  Human sodium phosphate transporter 4 (hNPT4/SLC17A3) as a common renal secretory pathway for drugs and urate.

Authors:  Promsuk Jutabha; Naohiko Anzai; Kenichiro Kitamura; Atsuo Taniguchi; Shuji Kaneko; Kunimasa Yan; Hideomi Yamada; Hidetaka Shimada; Toru Kimura; Tomohisa Katada; Toshiyuki Fukutomi; Kimio Tomita; Wako Urano; Hisashi Yamanaka; George Seki; Toshiro Fujita; Yoshinori Moriyama; Akira Yamada; Shunya Uchida; Michael F Wempe; Hitoshi Endou; Hiroyuki Sakurai
Journal:  J Biol Chem       Date:  2010-09-01       Impact factor: 5.157

Review 6.  Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation.

Authors:  Richard J Johnson; George L Bakris; Claudio Borghi; Michel B Chonchol; David Feldman; Miguel A Lanaspa; Tony R Merriman; Orson W Moe; David B Mount; Laura Gabriella Sanchez Lozada; Eli Stahl; Daniel E Weiner; Glenn M Chertow
Journal:  Am J Kidney Dis       Date:  2018-02-27       Impact factor: 8.860

7.  Type 1 sodium-dependent phosphate transporter (SLC17A1 Protein) is a Cl(-)-dependent urate exporter.

Authors:  Masafumi Iharada; Takaaki Miyaji; Takahiro Fujimoto; Miki Hiasa; Naohiko Anzai; Hiroshi Omote; Yoshinori Moriyama
Journal:  J Biol Chem       Date:  2010-06-21       Impact factor: 5.157

8.  Transmembrane peptide as potent inhibitor of oligomerization and function of human organic anion transporter 1.

Authors:  Peng Duan; Shanshan Li; Guofeng You
Journal:  Mol Pharmacol       Date:  2010-12-15       Impact factor: 4.436

9.  Interactions of stevioside and steviol with renal organic anion transporters in S2 cells and mouse renal cortical slices.

Authors:  Chutima Srimaroeng; Promsuk Jutabha; John B Pritchard; Hitoshi Endou; Varanuj Chatsudthipong
Journal:  Pharm Res       Date:  2005-06-08       Impact factor: 4.200

10.  Novobiocin is a potent inhibitor for human organic anion transporters.

Authors:  Peng Duan; Guofeng You
Journal:  Drug Metab Dispos       Date:  2009-03-12       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.